Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Urology ; 84(5): 1188-93, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25443932

ABSTRACT

OBJECTIVE: To investigate the incidence and presentation of ureteral obstruction after endoscopic injection of polyacrylate polyalcohol copolymer (PPC) for the treatment of vesicoureteral reflux, and to analyze its possible causes, together with histopathologic assessment. PATIENTS AND METHODS: The data of 189 patients who underwent endoscopic injection of PPC between May 2011 and December 2013 were retrospectively reviewed. After the injection, patients were followed up by urinalysis and ultrasonography monthly for 3 months. Control voiding cystouretrography was performed in the third postoperative month. Patients were then followed up by ultrasound every 3 months. If a new-onset hydroureteronephrosis (HUN) was observed, control ultrasound was performed monthly to follow the change in the degree of HUN. If a moderate or severe HUN was observed, technetium-99m mercaptoacetyltriglycine or dimercaptosuccinic acid scintigraphy was performed. For patients who needed open surgery, Cohen ureteroneocystostomy was performed. The distal 1 cm of the ureters was resected and examined histopathologically. RESULTS: One hundred eighty-nine patients with 268 refluxing ureters underwent endoscopic injection of PPC. Ureteral obstruction was observed in 3 ureters (1.1%), in 3 female patients of whom the degrees of reflux were grade 4, 5, and 5, respectively. Obstruction showed late onset in all 3 patients. Manifestations of obstruction included pain in 2 patients and recurrent febrile urinary tract infection with loss of function in scintigraphy in 1. All 3 patients underwent open ureteroneocystostomy. CONCLUSION: PPC may cause ureteral obstruction several months or even years after injection. Patients who undergo endoscopic treatment of PPC need long-term follow-up, despite reflux showing complete resolution.


Subject(s)
Acrylic Resins/therapeutic use , Endoscopy/adverse effects , Polymers/therapeutic use , Ureteral Obstruction/complications , Vesico-Ureteral Reflux/complications , Vesico-Ureteral Reflux/therapy , Acrylic Resins/adverse effects , Adolescent , Child , Child, Preschool , Female , Humans , Hydronephrosis/etiology , Infant , Male , Polymers/adverse effects , Postoperative Period , Retrospective Studies , Ultrasonography , Ureter/surgery , Urinary Tract Infections/etiology
2.
J Pediatr Surg ; 49(11): 1652-5, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25475812

ABSTRACT

BACKGROUND/PURPOSE: To evaluate the success rate of open ureteroneocystostomy (UNC) after failed endoscopic treatment of vesicoureteral reflux (VUR) in children and to discuss the reasons for failure under the light of histopathological findings. METHODS: The clinical data of 371 patients who underwent endoscopic injection for VUR at our institution for the treatment of VUR between January 2008 and January 2014 were reviewed. Patients who were submitted to open ureteral reimplantation following failed endoscopic injection were included in the study. RESULTS: Among 371 patients, 34 (49 ureters) were submitted to open UNC (9.1%). There were 22 female and 12 male patients. Three different injection materials were used; dextranomer/hyaluronic acid in 29, carbon-coated beans in 7 and polyacrylate polyalchohol copolymer in 13. Histological study revealed that the injected material was identified in 34 ureters as malpositioned. Control VCUG 6 months after UNC showed complete resolution in 46 of 47 ureters (97.87%). CONCLUSIONS: Previous endoscopic injection, although causing difficulty in dissection to some degree, does not alter the success rate of UNC. According to the histopathological findings, the cause of failure of injection seems to be attributable to incorrect plane of injection or leakage of the agent after injection.


Subject(s)
Cystostomy/methods , Dextrans/administration & dosage , Endoscopy/adverse effects , Hyaluronic Acid/administration & dosage , Ureter/surgery , Ureterostomy/methods , Vesico-Ureteral Reflux/surgery , Adolescent , Child , Child, Preschool , Female , Follow-Up Studies , Humans , Infant , Injections , Male , Retrospective Studies , Time Factors , Treatment Failure , Viscosupplements/administration & dosage
3.
Urol Int ; 92(2): 219-22, 2014.
Article in English | MEDLINE | ID: mdl-24335079

ABSTRACT

OBJECTIVE: To evaluate the early results of endoscopic treatment of vesicoureteral reflux (VUR) in children using polyacrylate polyalcohol copolymer (PPC). PATIENTS AND METHODS: We retrospectively reviewed 45 patients treated with subureteric injection of PPC in our clinic. The results of voiding cystouretrography performed on the 3rd postoperative month and the results of 1-year follow-up were evaluated. RESULTS: A total of 45 patients (57 ureters) underwent injection of PPC. The mean age of the patients was 6.5 years. There were 6 (10.5%) grade 1, 7 (12.2%) grade 2, 26 (45.6%) grade 3, 16 (28%) grade 4, and 2 (3.5%) grade 5 VUR. There were 11 overactive bladders, 2 duplex collecting systems, and 4 posterior urethral valves among the patients. Voiding cystouretrography postoperatively at the 3rd month showed that VUR had disappeared in 82.5% (47/57) of the ureters, downgraded to grade 2 and 3 in 7% (4/57), persisted in 5.2% (3/57) and upgraded in 5.2% (3/57). The success rate at the end of the first year was 98.1%. The procedure was free of complications such as fever, dysuria, lumbar pain or obstruction in all patients. No patient showed VUR recurrence at the end of the first year. CONCLUSIONS: The short-term results of our patients suggested that PPC can be safely and successfully used in the endoscopic treatment of VUR in children. However, further prospective, controlled trials showing the long-term results of the patients are needed.


Subject(s)
Acrylates/chemistry , Acrylic Resins/chemistry , Alcohols/chemistry , Endoscopy/methods , Polymers/chemistry , Vesico-Ureteral Reflux/surgery , Child , Child, Preschool , Female , Follow-Up Studies , Humans , Infant , Injections , Male , Prospective Studies , Retrospective Studies , Time Factors , Treatment Outcome , Ureteroscopy
4.
Pediatr Surg Int ; 26(6): 633-8, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20179951

ABSTRACT

BACKGROUND: Several modifications to an esophageal replacement approach have been described, using the left, the right, or the transverse colon as an interposition flap. Interposition of the left colon has become the most popular procedure. Intraoperative clamping of the arterial blood supply and venous drainage of the flap is a possible reason for ischemic flap failure. Thus, we designed a novel model to investigate whether erythropoietin (EPO), which has a tissue-protective effect in ischemia, would have any protective effect on prepared colon flaps in rats. METHODS: A total of 56 rats were randomly divided into four main groups, consisting of sham, sham + EPO, colon flap, and colon flap + EPO, and each main group was divided into two sub-groups. In the colon flap and colon flap + EPO groups, the colon flap was prepared and the pediculated free flap fixed tautly to the anterior abdominal wall. The sub-groups were subjected to post-reoperative histopathological investigation on the first and the seventh days, respectively. RESULTS: Our model was reliable for research related to colon interposition techniques. There was significant histopathological damage in the colon flap group both for the long and short limbs of the flap. On the other hand, EPO administration prevented the mucosal damage seen in the colon flap group. CONCLUSIONS: This study suggests that a colon flap attached tautly to the abdominal side wall simulates colon transposition techniques and also shows that intraperitoneal EPO markedly decreases flap damage in rats with prepared colon flaps.


Subject(s)
Angiogenesis Inducing Agents/administration & dosage , Colon/drug effects , Erythropoietin/administration & dosage , Intestinal Mucosa/drug effects , Ischemia/prevention & control , Animals , Antioxidants/administration & dosage , Colon/blood supply , Colon/transplantation , Disease Models, Animal , Intestinal Mucosa/blood supply , Male , Rats , Rats, Wistar , Surgical Flaps
5.
J Pediatr Surg ; 41(2): 352-7, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16481250

ABSTRACT

BACKGROUND AND PURPOSE: Despite the decreased mortality in gastroschisis (Gx), patients experience postoperative intestinal hypoperistalsis, malabsorption, and shortened bowel length. The trophic effects of recombinant human erythropoietin (rEpo) in the developing small bowel have been reported, increasing the length and height of the villi, and villous surface area. This study investigated the effects of rEpo on intestinal malfunction in the chick embryos with Gx. METHODS: Thirteen-day-old fertilized chicken eggs were used to create Gx model. Study groups included the following: group 1, control; group 2, Gx-only; group 3, Gx + 0.075% saline exchange; group 4, Gx + 10 IU rEpo exchange; group 5, Gx + 20 IU rEpo exchange. The bowels were evaluated by in vitro muscle strip technique, and the response was expressed as a percentage of the maximum carbachol-evoked contraction (Emax). In addition, parasympathetic ganglion cells per 10 plexuses and villi height were determined by light microscopy. Results were evaluated statistically by Mann-Whitney U, chi2, and Fisher's Exact test tests. RESULTS: Saline exchange had no effect on ganglion cell number (P = .63) and villi height (P = .10). In group 4, ganglion cell number was not increased (P = .82), but villi height increase was significant (P = .03). In Gx + 20 IU rEpo group, both the number of ganglia (P = .0001) and villi height (P = .002) were significantly increased. The decrease in contractility in group 2 (P = .0121) was significantly reversed by rEpo 20 IU treatment (P = .0216), no significant difference was obtained in groups 3 (P = .0809) and 4 (P = .1516) compared with group 2. CONCLUSION: These data suggest that rEpo has prokinetic effects on hypoperistalsis and restores bowel damage in Gx.


Subject(s)
Erythropoietin/pharmacology , Gastroschisis/physiopathology , Intestines/drug effects , Intestines/pathology , Peristalsis/drug effects , Animals , Chick Embryo , Recombinant Proteins
6.
J Pediatr Surg ; 40(10): 1632-6, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16226997

ABSTRACT

BACKGROUND/PURPOSE: Ureteropelvic junction (UPJ) obstruction is the most common cause of congenital hydronephrosis. Previous studies have reported that the excess amount of collagen restricting mobility and resiliency of the UPJ is the result of an impaired collagen production by anomalous smooth muscle cells (SMCs). Our purpose was to evaluate the role of SMC differentiation in the pathogenesis of UPJ obstruction. METHODS: Surgical specimens of UPJ from 21 patients (8 girls/13 boys) who were subjected to dismembered pyeloplasty were examined immunohistochemically using monoclonal antibodies against smooth muscle (SM) myosin heavy chain isoforms including SM1, SM2, and SMemb. The age ranged from 1 month to 13 years. Ureteropelvic walls taken from 14 forensic autopsy cases, with no urological abnormalities, served as age-matched control group. RESULTS: The immunohistochemical expression of SM1 and SM2 in UPJ obstruction was significantly increased when compared with controls (P < .05). In contrast, there was no statistical difference of expression of SMemb. CONCLUSION: Our findings supported the hypothesis that the primary anomaly in UPJ obstruction may be attributed to a malfunction of SMCs in the ureter.


Subject(s)
Kidney Pelvis , Muscle, Smooth/pathology , Ureteral Obstruction/etiology , Adolescent , Child , Child, Preschool , Female , Humans , Infant , Male
7.
Ulus Travma Acil Cerrahi Derg ; 11(2): 128-33, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15877243

ABSTRACT

BACKGROUND: In this study the results of non-operative management of pediatric hepatic injury after blunt abdominal trauma were evaluated. METHODS: Multitrauma patients (n = 498) admitted between 1998 and 2002 were analysed as for mechanism of trauma retrospectively. Liver injuries were classified according to the American Association for the Surgery of Trauma's Organ Injury Scaling System. Liver function tests, transfusion status, duration of hospital stay, complications, and operative intervention needed were recorded. RESULTS: Seventy-five patients had liver injuries. The mean age was 6.7 years and male/female was 2.5/1. Number of patients in terms of injury grade: I: 15, II: 26, III: 29, IV: 4, V: 1. There was no significant difference between mean blood pressures, heart rates, and hematocrite values on admission and post-stabilisation. In three of 21 transfused patients, it exceeded 40 ml/kg and two of them were operated. The mean pediatric trauma score was +2. As a complication biloma was encountered in one patient. One patient with grade V hepatic injury died in the operating room because of heavy bleeding. The average hospital stay was 8,6 days. CONCLUSION: Our results support the efficacy of non-operative management of any grade hepatic injuries due to blunt abdominal trauma, with resultant low complication and mortality rates and shorter hospital stays.


Subject(s)
Abdominal Injuries/epidemiology , Abdominal Injuries/therapy , Liver/injuries , Abdominal Injuries/blood , Abdominal Injuries/pathology , Adolescent , Alanine Transaminase/blood , Blood Transfusion/statistics & numerical data , Child , Child, Preschool , Female , Humans , Infant , Length of Stay , Male , Medical Records , Postoperative Complications , Retrospective Studies , Trauma Severity Indices , Turkey/epidemiology
8.
J Pediatr Surg ; 39(7): 1073-6, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15213902

ABSTRACT

BACKGROUND/PURPOSE: Delayed presentation of congenital diaphragmatic hernia (CDH) has been considered rare, and clinical manifestations differ from the more common newborn entity. Associated malformations in late-appearing CDH have been reported in a few patients. The authors reviewed their clinical experience to catalogue the frequency and clinical importance of associated malformations in patients with late-presenting CDH. METHODS: The records of patients greater than 1 month of age with Bochdalek type CDH treated in the authors' clinic, from 1991 to 2001, were retrospectively reviewed. Twenty patients (age range, 1 month to 10 years) were included in the study. RESULTS: Associated malformations were documented in 16 of the patients (80%) and included malrotation in 12 patients, umbilical hernia in 2, pulmonary hypoplasia in 4, pulmonary sequestration in 1, gastroesophageal duplication cyst coexisting with polysplenia in 1, atrial septal defect and ventricular septal defect in 1, hydronephrosis in 1, wandering spleen in 1, talipes equinovarus in 1, and type I diabetes mellitus in 1. CONCLUSIONS: The results of this study show a significant incidence and a wide spectrum of associated malformations. These findings suggest that patients with late CDH should be evaluated carefully for additional anomalies that may help to establish correct diagnosis and treatment.


Subject(s)
Abnormalities, Multiple/diagnosis , Heart Defects, Congenital/diagnosis , Hernia, Diaphragmatic/diagnosis , Hernia, Diaphragmatic/surgery , Lung/abnormalities , Adolescent , Child , Child, Preschool , Female , Follow-Up Studies , Heart Defects, Congenital/surgery , Hernia, Umbilical/diagnosis , Humans , Hydronephrosis/diagnosis , Infant , Intestines/abnormalities , Lung/diagnostic imaging , Male , Radiography , Reoperation , Spleen/abnormalities , Spleen/surgery , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...